EC Number   |
Substrates   |
Products   |
Reversibility   |
|---|
6.2.2.2 | ATP + a [PatE2]-(L-amino acyl-L-cysteine) |
engineered PatE2 protein with single core peptide sequence ITACITFC |
AMP + diphosphate + a [PatE2]-(1S,4R)-2-(C-substituted-aminomethyl)-4-acyl-2-thiazoline |
- |
? |
6.2.2.2 | ATP + [BalhA1 variant C40S]-(L-amino acyl-L-serine) |
- |
ADP + phosphate + [BalhA1 variant C40S]-(S,S)-2-(Csubstituted-aminomethyl)-4-acyl-2-oxazoline |
- |
? |
6.2.2.2 | ATP + [BalhA1 variant C40T]-(L-amino acyl-L-threonine) |
- |
ADP + phosphate + [BalhA1 variant C40T]-(S,S)-2-(C-substituted-aminomethyl)-4-acyl-5-methyl-2-oxazoline |
- |
? |
6.2.2.2 | ATP + [BalhA1]-(L-amino acyl-L-cysteine) |
- |
ADP + phosphate + [BalhA1]-(1S,4R)-2-(C-substituted-aminomethyl)-4-acyl-2-thiazoline |
- |
? |
6.2.2.2 | ATP + [PatE2K]-(L-amino acyl-L-cysteine) |
- |
ADP + phosphate + [PatE2K]-(1S,4R)-2-(C-substituted-aminomethyl)-4-acyl-2-thiazoline |
- |
? |
6.2.2.2 | ATP + [PatE2K]-(L-amino acyl-L-threonine) |
- |
ADP + phosphate + [PatE2K]-(S,S)-2-(C-substituted-aminomethyl)-4-acyl-5-methyl-2-oxazoline |
- |
? |
6.2.2.2 | ATP + [PatEalpha]-(L-amino acyl-L-cysteine) |
- |
ADP + phosphate + [PatEalpha]-(1S,4R)-2-(C-substituted-aminomethyl)-4-acyl-2-thiazoline |
- |
? |
6.2.2.2 | ATP + [PatEalpha]-(L-amino acyl-L-threonine) |
- |
ADP + phosphate + [PatEalpha]-(S,S)-2-(C-substituted-aminomethyl)-4-acyl-5-methyl-2-oxazoline |
- |
? |
6.2.2.2 | ATP + [PatEDm]-(L-amino acyl-L-cysteine) |
- |
ADP + phosphate + [PatEDm]-(1S,4R)-2-(C-substituted-aminomethyl)-4-acyl-2-thiazoline |
- |
? |
6.2.2.2 | ATP + [PatEDm]-(L-amino acyl-L-threonine) |
- |
ADP + phosphate + [PatEDm]-(S,S)-2-(C-substituted-aminomethyl)-4-acyl-5-methyl-2-oxazoline |
- |
? |